Neurocrine (NBIX) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • Wednesday
Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales GuidancePRNewsWire • Wednesday
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 10/23/24
Neurocrine: A Buy Amid CNS Pipeline Growth And Ingrezza's Strength (Rating Upgrade)Seeking Alpha • 10/10/24
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2024 Financial ResultsPRNewsWire • 10/09/24
Neurocrine Biosciences Presents Interim Data Demonstrating Robust and Sustained Improvements in Chorea Associated With Huntington's Disease Through Week 104 Irrespective of Antipsychotic UsePRNewsWire • 09/30/24
Neurocrine Biosciences to Participate at the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Virtual SummitPRNewsWire • 09/19/24
Neurocrine Biosciences Provides Update on ERUDITE™ Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with SchizophreniaPRNewsWire • 09/12/24
Neurocrine Biosciences to Participate at the 2024 Cantor Global Healthcare ConferencePRNewsWire • 09/10/24
Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568GlobeNewsWire • 09/01/24
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades StockBenzinga • 08/29/24
Neurocrine Biosciences: Disappointing Data From A Key Readout Hits The Stock HardSeeking Alpha • 08/28/24
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints InvestorsBenzinga • 08/28/24
Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568GlobeNewsWire • 08/28/24
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1117568 in Adults with SchizophreniaPRNewsWire • 08/28/24
Neurocrine Biosciences to Present at the Canaccord Genuity 44th Annual Growth ConferencePRNewsWire • 08/07/24